Nevertheless, there is a dire need for T cell-inducing vaccines, as both CD4+ and CD8+ T cell responses have been deemed crucial for protection against different pathogens, such as Plasmodium falciparum, HIV and Mycobacterium tuberculosis, and for successful treatment of cancer. Here, CD8A is linked to cancer.